- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT07267949
Klinisk randomiseret fase 2-forsøg med AP31969 versus placebo til rytmekontrol af atrieflimren (END-AF-1)
Klinisk randomiseret fase 2-forsøg af AP31969 versus placebo til rytmekontrol af atrieflimren
A clinical Randomized Phase 2 Trial of AP31969 versus Placebo for Rhythm Control of Atrial Fibrillation.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The key goal of this clinical trial is to assess the effectiveness of different doses of AP31969 in lowering Atrial Fibrillation (AF) burden and its safety.
Participants will be randomly assigned to one of the following groups:
- AP31969 at 100 mg, 200 mg, or 350 mg doses
- AP31969 500 mg (not included at the trial start)
- Placebo (inactive treatment and has no active properties). The placebo group serves as the comparator for AP31969. All treatments are given orally, twice daily.
The trial includes 3 periods: screening (up to 4 weeks), treatment (12 weeks), and follow-up (30 days). The duration of the trial for a participant is approximately 20 weeks.
Participants will receive an implantable loop recorder and undergo assessments during the visits at specific times, for example blood and urine analyses, and electrocardiogram.
Undersøgelsestype
Tilmelding (Anslået)
Fase
- Fase 2
Kontakter og lokationer
Studiekontakt
- Navn: Birgitte Vestbjerg
- Telefonnummer: +0045 2077 2575
- E-mail: bve@acesionpharma.com
Studiesteder
-
-
PD
-
Plovdiv, PD, Bulgarien, 4002
- Rekruttering
- UMHAT "Sveti Georgi" EAD, Department of Invasive Cardiology
-
-
SOF
-
Sofia, SOF, Bulgarien, 1000
- Rekruttering
- Acibadem City Clinic, Cardiology Department
-
Sofia, SOF, Bulgarien, 1365
- Trukket tilbage
- MHAT National Cardiology Hospital EAD, Cardiology Department
-
Sofia, SOF, Bulgarien, 1431
- Rekruttering
- Aleksandrovska University Hospital, Clinic of Cardiology
-
-
VAR
-
Varna, VAR, Bulgarien, 9000
- Rekruttering
- SHATC Cardiolife, Invasive Cardiology
-
Varna, VAR, Bulgarien, 9020
- Rekruttering
- Medical Center Nova Clinic
-
-
-
-
-
Hellerup, Danmark, 2730
- Rekruttering
- University Hospital Herlev and Gentofte Department of Cardiology
-
Viborg, Danmark, 8800
- Rekruttering
- Viborg Hospital, Department of Cardiology
-
-
-
-
-
Arnhem, Holland, 6815 AD
- Rekruttering
- Rijnstate Ziekenhuis, Cardiology Department
-
Deventer, Holland, 7416 SE
- Rekruttering
- Deventer Ziekenhuis, Cardiology Department
-
Groningen, Holland, 9728 NT
- Rekruttering
- Martini Hospital Groningen, Cardiology Department
-
Haarlem, Holland, 2035 RC
- Rekruttering
- Spaarne Gasthuis, Cardiology Department
-
Leeuwarden, Holland, 8934 AD
- Trukket tilbage
- Frisius MC Leeuwarden, Hart- en Vaatcentrum
-
Maastricht, Holland, 6229 HX
- Aktiv, ikke rekrutterende
- Maastricht University Medical Center, Cardiology Department
-
The Hague, Holland, 2545 AA
- Rekruttering
- HagaZiekenhuis, Cardiology/Electrophysiology Unit
-
Tiel, Holland, 4002 WP
- Rekruttering
- Rivierenland Hospital, Cardiology Department
-
Veldhoven, Holland, 5504 DB
- Rekruttering
- Máxima Medisch Centrum, Cardiology Department
-
-
-
-
-
Milan, Italien, 20162
- Rekruttering
- ASST Grande Ospedale Metropolitano Niguarda Cardiology 3 - Electrophysiology "De Gasperis" Cardio Center
-
Milan, Italien, 20122
- Ikke rekrutterer endnu
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Department of Cardio - Thoracic- Vascular Diseases,
-
Modena, Italien, 30174
- Rekruttering
- University of Modena and Reggio Emilia, Policlinico di Modena, Cardiology Department
-
-
BO
-
Bologna, BO, Italien, 40138
- Rekruttering
- Policlinico Sant'Orsola Cardiology Department
-
-
FE
-
Cona, FE, Italien, 444124
- Rekruttering
- Arcispedale Sant'Anna, Cardiology Department
-
-
VE
-
Mestre, VE, Italien, 30174
- Rekruttering
- Dell'Angelo Hospital, Cardiology Department
-
-
-
-
-
Bydgoszcz, Polen, 85-231
- Rekruttering
- Centrum Medyczne KERmed Cardiology Department
-
Chrzanów, Polen, 85-231
- Rekruttering
- Małopolskie Centrum Sercowo-Naczyniowe PAKS Oddział Intensywnej Opieki Kardiologicznej
-
Dąbrowa Górnicza, Polen, 41-300
- Rekruttering
- Polsko-Amerykańskie Kliniki Serca III Oddział Kardiologii Inwazyjnej, Angiologii i Elektrokardiologii
-
Katowice, Polen, 40-635
- Ikke rekrutterer endnu
- Upper-Silesian Medical Center 2nd Department of Cardiology
-
Katowice, Polen, 40-635
- Ikke rekrutterer endnu
- Gornoslaskie Centrum Medyczne im. prof. Leszka Gieca Slaskiego Uniwersytetu Medycznego w Katowicach
-
Szczecin, Polen, 70-419
- Rekruttering
- One Day Med Sp. z o.o. Clinical Trials Department
-
Tychy, Polen, 43-100
- Rekruttering
- Polsko-Amerykańskie Kliniki Serca X Oddział Kardiologii Inwazyjnej, Elektrofizjologii i Elektrostymulacji w Tychach im
-
-
-
-
-
Belgrade, Serbien
- Rekruttering
- University Clinical Centre of Serbia Department for Intensive Care in Arrhythmology
-
Belgrade, Serbien
- Rekruttering
- Institute for Cardiovascular Disease "Dedinje" Department for Electrophysiology
-
Kamenitz, Serbien
- Rekruttering
- Institute for Cardiovascular Diseases Vojvodina Department of Interventional Electrophysiology
-
Kragujevac, Serbien
- Rekruttering
- University Clinical Center Kragujevac Clinic of Cardiology (Depar. Electrophysiology)
-
Niš, Serbien
- Rekruttering
- University Clinical Center Nis Clinic for Cardiovascular Diseases Bulevar
-
Užice, Serbien, 33100
- Rekruttering
- Health Center Uzice Cardiology Department
-
-
-
-
-
Coburg, Tyskland, 96450
- Rekruttering
- Sana Kliniken Oberfranken, Klinikum Coburg Kardiologie und Innere Medizin
-
Frankfurt, Tyskland, 60590
- Rekruttering
- Universitätsklinikum Frankfurt Medizinische Klinik III - Kardiologie, Angiologie, Hämostaseologie, Nephrologie
-
Hamburg, Tyskland, 20246
- Rekruttering
- Universitaets Klinikum Hamburg-Eppendorf (UKE Hamburg), Kardiologie
-
-
-
-
-
Budapest, Ungarn, 1122
- Rekruttering
- Semmelweis Egyetem Városmajori Sziv- és Érsebészeti Klinika
-
Budapest, Ungarn, 1023
- Rekruttering
- Budai Irgalmasrendi Kórház
-
Sopron, Ungarn, 9400
- Trukket tilbage
- Soproni Gyógyközpont Soproni Erzsébet Oktató Kórház és Rehabilitációs Intézet
-
Szeged, Ungarn, 6725
- Rekruttering
- Szent-Györgyi Albert Klinikai Központ, Belgyógyászati Klinika
-
Szolnok, Ungarn, 5000
- Rekruttering
- Jász-Nagykun-Szolnok Vármegyei Hetényi Géza Kórház-Rendelőintézet
-
Zalaegerszeg, Ungarn, 8900
- Rekruttering
- Belvárosi Egészségház, Platán Magánklinika
-
-
Hungary
-
Pécs, Hungary, Ungarn, 7622
- Ikke rekrutterer endnu
- Pécsi Tudományegyetem Szivgyógyászati Klinika (Cardiology Clinic, University of Pecs)
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
-
Willing and able to provide written informed consent.
-
Age 18 or older.
-
ECG documented diagnosis of paroxysmal or persistent AF.
-
AF history at screening indicating an expected AF burden of 1-90%, i.e., at least 1 self-terminating AF episode within 4 months prior to the screening visit.
-
AF burden of ≥ 1% and ≤ 90% assessed with an ECG patch device during the screening period prior to the randomisation visit.
-
Investigator and participant agreement to avoid non-trial related rhythm control intervention for the duration of the trial, including:
- Antiarrhythmic drug class I and/or III (including amiodarone)
- Electrical or pharmacological cardioversion
- AF ablation procedure
-
Willing to have a loop recorder implanted.
Exclusion Criteria:
- Prior AF ablation procedure other than pulmonary vein isolation (PVI) only.
- Any of the following events within 4 weeks prior to the screening visit: Myocardial infarction, Unstable angina pectoris, Stroke or transient, ischaemic attack, Percutaneous coronary intervention (PCI), Coronary artery bypass graft (CABG), Peripheral revascularisation procedure.
- Cardiac pacing device e.g. pacemaker and cardiac resynchronization therapy device with atrial or ventricular pacing for > 5% of the time or existing implantable loop recorder.
- Heart failure, New York Heart Association class III (3) or IV (4).
- Left ventricular ejection fraction < 40% based on imaging (e.g. echocardiography) performed within 6 months prior to or during the screening visit.
- Clinically significant valvular heart disease, including severe aortic stenosis, severe mitral regurgitation and/or severe mitral stenosis, in the opinion of the investigator.
- QTc (Fridericia, QTcF) interval > 450 ms for males and > 470 ms for females at screening.
- eGFR <60 mL/min /1.73 m² based on creatine and CKD-EPI formula
- Use of antiarrhythmic drug class I and/or III within 7 days or, for amiodarone, within 3 months prior to the screening visit.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Behandling
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Firedobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: AP31969 100 mg
Tablets, Twice daily, 12 Weeks |
Tablets, Oral, Twice daily. |
|
Eksperimentel: AP31969 200 mg
Tablets, Twice daily, 12 Weeks |
Tablets, Oral, Twice daily. |
|
Eksperimentel: AP31969 350 mg
Tablets, Twice daily, 12 Weeks |
Tablets, Oral, Twice daily. |
|
Eksperimentel: AP31969 500 mg
Tablets, Twice daily, 12 Weeks |
Tablets, Oral, Twice daily. |
|
Placebo komparator: Placebo
Tablets, Twice daily, 12 Weeks |
Tablets, oral, Twice daily. |
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Atrial fibrillation burden
Tidsramme: From week 2 to week 12
|
Measured through implantable loop recorder. Calculated as the amount of time with AF relative to the amount of time the participant is under observation (expressed as a %). |
From week 2 to week 12
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of atrial fibrillation episodes
Tidsramme: From week 2 to week 12
|
Measured through implantable loop recorder. |
From week 2 to week 12
|
|
Change from baseline in Atrial Fibrillation Effect on Quality-of-Life
Tidsramme: Week 12
|
Patient reported outcome. Reporting on a scale of 1 to 7, where 7 is the worse outcome. |
Week 12
|
|
Number of ventricular tachycardia episodes > 30 seconds of duration
Tidsramme: From week 0 to week 12
|
Measured through implantable loop recorder. |
From week 0 to week 12
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Anslået)
Studieafslutning (Anslået)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- AP31969-M201
- 2025-521377-14-00 (Ctis)
- 2025 (U.S. NIH-bevilling/kontrakt)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
IPD-planbeskrivelse
Qualified external researchers may request access to anonymized data and needed trial documentation. Requests are evaluated on the basis of scientific merit. Any use of and access to the data must respect the privacy of the participants and will only be provided if applicable laws and regulations allow this.
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .